Related Experiment Video
Updated: Apr 18, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Diagnosis and Management of Hepatitis C Virus Infection
Ronita Mukherjee1, Andrew Burns1, Diane Rodden1
1Keck Graduate Institute of Applied Life Sciences, Claremont, CA, USA.
Insights
Hepatitis C virus (HCV) diagnosis relies on serological and molecular assays for detection and monitoring. Current methods are mature but lack accessibility in low-resource regions, hindering effective disease management globally.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis C virus (HCV) infection affects over 200 million globally, with rising incidence in developing nations.
- Chronic HCV infection leads to significant liver disease, imposing economic burdens and reducing quality of life, particularly in resource-poor settings.
- Effective diagnosis, treatment selection, and monitoring are crucial for managing HCV and preventing disease progression.
Purpose of the Study:
- To review current diagnostic methods for Hepatitis C virus (HCV).
- To highlight the limitations of existing technologies in resource-limited settings.
- To emphasize the need for accessible diagnostic solutions in high-prevalence areas.
Main Methods:
- Review of serological assays for initial HCV diagnosis (anti-HCV antibodies).
- Analysis of molecular assays for confirmation, viral load quantification, and genotyping.
- Examination of biomarker assays for liver function assessment and disease staging.
Main Results:
- Established diagnostic methods include serological, molecular, and biomarker assays.
- These mature technologies are standard in high-resource countries with developed laboratory infrastructure.
- A significant gap exists in available technologies for low-resource areas with high HCV prevalence.
Conclusions:
- Current HCV diagnostic and monitoring tools are well-established but not universally accessible.
- There is a critical need for developing and implementing cost-effective, accessible diagnostic technologies for HCV in low-resource regions.
- Improving diagnostic accessibility is key to controlling HCV burden in underserved populations.
Abstract:
The hepatitis C virus (HCV) infects more than 200 million people globally, with increasing incidence, especially in developing countries. HCV infection frequently progresses to chronic liver disease, creating a heavy economic burden on resource-poor countries and lowering patient quality of life. Effective HCV diagnosis, treatment selection, and treatment monitoring are important in stopping disease progression. Serological assays, which detect anti-HCV antibodies in the patient after seroconversion, are used for initial HCV diagnosis. Qualitative and quantitative molecular assays are used to confirm initial diagnosis, determine viral load, and genotype the dominant strain. Viral load and genotype information are used to guide appropriate treatment. Various other biomarker assays are performed to assess liver function and enable disease staging. Most of these diagnostic methods are mature and routinely used in high-resource countries with well-developed laboratory infrastructure. Few technologies, however, are available that address the needs of low-resource areas with high HCV prevalence, such as Africa and Southeast Asia.
More Related Videos
Related Concept Videos
01:25Hepatitis
01:28Viral Hepatitis I: Introduction
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:27Cytomegalovirus Disease
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: